ANTACID TABLETS

N/A

Manufactured by Rising Pharma Holdings, Inc.

92 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ANTACID TABLETS

ANTACID TABLETS is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Rising Pharma Holdings, Inc.. The most commonly reported adverse reactions for ANTACID TABLETS include FATIGUE, GAIT DISTURBANCE, PRODUCT DOSE OMISSION ISSUE, CONSTIPATION, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ANTACID TABLETS.

Top Adverse Reactions

FATIGUE3 reports
GAIT DISTURBANCE3 reports
PRODUCT DOSE OMISSION ISSUE3 reports
CONSTIPATION2 reports
DYSPNOEA2 reports
MEMORY IMPAIRMENT2 reports
PAIN2 reports
PRODUCT SUBSTITUTION ISSUE2 reports
RED BLOOD CELL COUNT DECREASED2 reports
SOMNOLENCE2 reports
STOMATITIS2 reports
ACUTE KIDNEY INJURY1 reports
ANAEMIA1 reports
ANKLE FRACTURE1 reports
ANTINUCLEAR ANTIBODY POSITIVE1 reports
APHONIA1 reports
ASTHENIA1 reports
BLINDNESS1 reports
BLOOD GLUCOSE FLUCTUATION1 reports
BLOOD GLUCOSE INCREASED1 reports
BRAIN FOG1 reports
BURNING SENSATION1 reports
CARDIAC FAILURE1 reports
COAGULOPATHY1 reports
COMPLETED SUICIDE1 reports
COVID 191 reports
DIARRHOEA1 reports
DISABILITY1 reports
DIZZINESS1 reports
DRUG INEFFECTIVE1 reports
DYSPHAGIA1 reports
DYSPNOEA EXERTIONAL1 reports
ECZEMA1 reports
EYE IRRITATION1 reports
FAECES PALE1 reports
FALL1 reports
HAEMATOCHEZIA1 reports
HEADACHE1 reports
HYPERTENSION1 reports
HYPERTRANSAMINASAEMIA1 reports
IMMUNE MEDIATED MYOSITIS1 reports
INCOHERENT1 reports
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS1 reports
INFLUENZA1 reports
INTENTIONAL PRODUCT USE ISSUE1 reports
JOINT SWELLING1 reports
LABELLED DRUG DRUG INTERACTION MEDICATION ERROR1 reports
LOSS OF CONSCIOUSNESS1 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES1 reports
LUNG NEOPLASM MALIGNANT1 reports
MACROCYTOSIS1 reports
MUSCULAR WEAKNESS1 reports
MYALGIA1 reports
NAUSEA1 reports
NERVE INJURY1 reports
NEUTROPENIA1 reports
NO ADVERSE EVENT1 reports
OCULAR DISCOMFORT1 reports
OFF LABEL USE1 reports
PAIN IN EXTREMITY1 reports
PARAESTHESIA1 reports
PERFORATION1 reports
PERITONITIS1 reports
PLATELET COUNT DECREASED1 reports
POLYARTHRITIS1 reports
PRODUCT QUALITY ISSUE1 reports
PRODUCT USE ISSUE1 reports
PRURITUS1 reports
RADIOISOTOPE SCAN ABNORMAL1 reports
RESPIRATORY FAILURE1 reports
ROSACEA1 reports
SIGHT DISABILITY1 reports
SURGERY1 reports
TEMPERATURE INTOLERANCE1 reports
THYROID MASS1 reports
URINARY RETENTION1 reports
URINARY TRACT INFECTION1 reports
WHITE BLOOD CELL COUNT DECREASED1 reports

Report Outcomes

Out of 29 classified reports for ANTACID TABLETS:

Serious 55.2%Non-Serious 44.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female21 (72.4%)
Male8 (27.6%)

Reports by Age

Age 412 reports
Age 512 reports
Age 652 reports
Age 161 reports
Age 431 reports
Age 461 reports
Age 551 reports
Age 601 reports
Age 711 reports
Age 741 reports
Age 771 reports
Age 781 reports
Age 791 reports
Age 861 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ANTACID TABLETS?

This profile reflects 92 FDA FAERS reports that mention ANTACID TABLETS. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ANTACID TABLETS?

Frequently reported terms in FAERS include FATIGUE, GAIT DISTURBANCE, PRODUCT DOSE OMISSION ISSUE, CONSTIPATION, DYSPNOEA, MEMORY IMPAIRMENT. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ANTACID TABLETS?

Labeling and FAERS entries often list Rising Pharma Holdings, Inc. in connection with ANTACID TABLETS. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.